Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2023-01-10 00:00:00 ET · period of report 2023-01-06 · accession 0001209191-23-002829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-10 | 2023-01-06 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $43.24 | +400 | 16.0K | +3% | +$17.3K |
| D | 2023-01-10 | 2023-01-06 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $125.00 | -400 | 15.6K | -2% | -$50.0K |
| D | 2023-01-10 | 2023-01-06 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $43.24 | -400 | 53.1K | -0.7% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-06 | M | A | 400 | $43.24 | 16,043 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-06 | S | D | 400 | $125.00 | 15,643 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option | 2023-01-06 | M | D | 400 | $43.24 | 53,143 | D | $43.24 · — to 2027-02-06 | 400 Common Stock | (F2) Option granted February 06, 2017 and vested monthly over four years. |